http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014094015-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate | 2014-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2676041dde83664fdeffe47e77d65d6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_697dbee5d7a99cce516e0579ac5b8816 |
publicationDate | 2014-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2014094015-A |
titleOfInvention | Recurrent gene fusion in prostate cancer |
abstract | Methods for recurrent gene fusion as diagnostic markers and clinical targets for prostate cancer are provided. The method includes collecting a sample from a patient, SLC45A3, HERV-K — 22qll. 23, and detection of presence or absence of a gene fusion having a 5 ′ portion derived from a transcription control region of an androgen-regulated gene selected from the group consisting of C15ORF21 and a 3 ′ portion derived from an ETS family member gene in a sample A method of diagnosing prostate cancer in a patient, wherein the presence of the gene fusion in the sample is indicative of the patient's prostate cancer. [Selection figure] None |
priorityDate | 2007-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1332.